Stoke Therapeutics

Stoke Therapeutics is an American biopharmaceutical company dedicated to developing antisense oligonucleotide drugs that target RNA splicing to increase gene expression. Through its TANGO technology platform, which targets the amplification of nuclear gene products, it provides treatment solutions for spinal muscular atrophy (SMA), applicable to tissues such as the central nervous system, eyes, and liver.